Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report

Mrinal Gupta; Paul S. Yamauchi; Martine Bagot; Jacek Szepietowski; Shibani Bhatia; Torello Lotti; Mohamad Goldust

doi:10.1002/ccr3.2971

Clinical Case Reports (Sep 2020)

Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report

Mrinal Gupta,
Paul S. Yamauchi,
Martine Bagot,
Jacek Szepietowski,
Shibani Bhatia,
Torello Lotti,
Mohamad Goldust

Affiliations

Mrinal Gupta: Treatwell Skin Centre Jammu India
Paul S. Yamauchi: Dermatology Institute and Skin Care Center Santa Monica California USA
Martine Bagot: AP‐HP Dermatology Department Saint‐Louis Hospital INSERM U976 Université Paris Diderot‐Paris VII Sorbonne Paris Cité Paris France
Jacek Szepietowski: Department of Dermatology, Venereology and Allergology Wroclaw Medical University Wroclaw Poland
Shibani Bhatia: Department of Dermatology, Venereology and Leprosy Kasturba medical college Manipal Manipal Academy of Higher Education Manipal India
Torello Lotti: University of Studies Guglielmo Marconi Rome Italy
Mohamad Goldust: Mazandaran University of Medical Sciences Sari Iran

DOI: https://doi.org/10.1002/ccr3.2971
Journal volume & issue: Vol. 8, no. 9
pp. 1647 – 1650

Abstract

Read online

Abstract Recombinant interferon beta‐1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords